Littérature scientifique sur le sujet « HYPERTENSIVE DRUGS »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Sommaire
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « HYPERTENSIVE DRUGS ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "HYPERTENSIVE DRUGS"
Wilson, J., M. A. Orchard, A. A. Spencer, J. A. Davies et C. R. M. Prentice. « Anti-Hypertensive Drugs Non-Specifically Reduce “Spontaneous” Activation of Blood Platelets ». Thrombosis and Haemostasis 62, no 02 (1989) : 776–80. http://dx.doi.org/10.1055/s-0038-1646901.
Texte intégralO'Collins, Victoria E., Geoffrey A. Donnan, Malcolm R. Macleod et David W. Howells. « Hypertension and Experimental Stroke Therapies ». Journal of Cerebral Blood Flow & ; Metabolism 33, no 8 (5 juin 2013) : 1141–47. http://dx.doi.org/10.1038/jcbfm.2013.88.
Texte intégralBhandary, Apeksha, et Prasan R. Bhandari. « Drug usage pattern of anti-hypertensive drugs in elderly diabetic, hypertensive in-patients with or without impaired renal function in a tertiary care hospital ». International Journal of Basic & ; Clinical Pharmacology 7, no 4 (23 mars 2018) : 696. http://dx.doi.org/10.18203/2319-2003.ijbcp20181172.
Texte intégralRisna, Amalia, Jauhar Latifah, Linda Permata Sari, Ronalisa Ronalisa, Henny Maryani et Difa Intannia. « PROFIL PERESEPAN PENGGUNAAN ANTIHIPERTENSI PADA PASIEN RAWAT JALAN DI PUSKESMAS SUNGAI ULIN PERIODE OKTOBER 2020 ». Jurnal Insan Farmasi Indonesia 5, no 1 (29 mai 2022) : 8–15. http://dx.doi.org/10.36387/jifi.v5i1.913.
Texte intégralCífková, Renata. « Antiplatelet and Lipid-lowering Drugs in Hypertension ». European Cardiology Review 9, no 1 (2014) : 16. http://dx.doi.org/10.15420/ecr.2014.9.1.16.
Texte intégralRajak, Devraj, Deepali Sahu, Anushree Jain, Rubeena Khan, Basant Khare, Prateek Kumar Jain et Bhupendra Singh Thakur. « Review on Toxicity of Antihypertensive Drugs ». Asian Journal of Dental and Health Sciences 2, no 4 (15 décembre 2022) : 64–68. http://dx.doi.org/10.22270/ajdhs.v2i4.28.
Texte intégralUllah, Mohammad, Suman Kumar Saha, Md Toufiqur Rahman, Md Abdul Karim et Rashid Ahmed. « Nonadherence to Drugs among the Hypertensive Patients in Outpatient Department of a Secondary Hospital of Bangladesh ». Cardiovascular Journal 11, no 2 (27 février 2019) : 105–13. http://dx.doi.org/10.3329/cardio.v11i2.40409.
Texte intégralRiungu, Dianah Kathambi, et Patrick Mbataru. « Determinants of Accessibility of Hypertensive Drugs by Adult Patients Under Sustainable Development Goal Three in Nairobi City County, Kenya ». International Journal of Current Aspects 5, no 4 (22 novembre 2021) : 108–19. http://dx.doi.org/10.35942/ijcab.v5i4.214.
Texte intégralWalker, James Johnston. « Hypertensive Drugs in Pregnancy ». Clinics in Perinatology 18, no 4 (décembre 1991) : 845–73. http://dx.doi.org/10.1016/s0095-5108(18)30499-8.
Texte intégralBrubaker, R. F. « Ocular hypertensive drugs—Overview ». Experimental Eye Research 55 (septembre 1992) : 185. http://dx.doi.org/10.1016/0014-4835(92)90845-j.
Texte intégralThèses sur le sujet "HYPERTENSIVE DRUGS"
Nievelstein, Hubert Nicolas Maria Willem. « Hemodynamic effects of antihypertensive drugs in conscious spontaneously hypertensive rats ». Maastricht : Maastricht : Rijksuniversiteit Limburg ; University Library, Maastricht University [Host], 1987. http://arno.unimaas.nl/show.cgi?fid=5367.
Texte intégralBeaubien, Eliot R. « Non-steroidal anti-inflammatory drugs and the risk of end stage renal disease in hypertensive individuals ». Thesis, McGill University, 2004. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=81593.
Texte intégralStudy design. We conducted a nested case-control study within a cohort of 77,887 hypertensive adult subjects within the province of Saskatchewan, Canada.
Outcome. The primary outcome was ESRD, defined by chronic dialysis or renal transplantation.
Exposure. NSAID exposure was determined using prescription records, for various time windows up to 10 years preceding the onset of end stage renal disease.
Statistical analysis. Rate ratios (RR) were estimated with 95% confidence intervals using conditional logistic regression, adjusting for potential confounding variables and stratified for effect modifiers.
Results. We identified 397 cases and 7,399 controls. In subjects followed for at least 10 years continuous NSAID use was observed in 20.8% of cases and 17.9% of controls (RR = 1.18, 95% CI 0.68--2.05). Additionally, neither early (RR = 1.10, 95% CI 0.50--2.41) nor late (RR = 0.81, 95% CI 0.32--2.04) NSAID exposure was associated with ESRD during this time period. Evaluation of other time windows (0--2 years, 2--5 years and 5--10 years) and NSAID dosing provided similar results. Results were not modified by loop diuretic and angiotensin converting enzyme inhibitor use.
Conclusion. Up to 10 years of non-steroidal anti-inflammatory drug use does not appear to influence the development of end stage renal disease. These results however may be influenced by unmeasured co-morbidities and confounding by "contra-indication".
Komulainen, S. (Silja). « Effect of antihypertensive drugs on blood pressure during exposure to cold:experimental study in normotensive and hypertensive subjects ». Doctoral thesis, University of Oulu, 2007. http://urn.fi/urn:isbn:9789514286131.
Texte intégralTiivistelmä Tutkimuksen tarkoituksena oli selvittää eri mekanismeilla vaikuttavien verenpainelääkkeiden vaikutusta verenpainevasteisiin ja sydämen lyöntitiheyteen kylmässä sekä verrata erilaisten kylmäaltistusten vaikutusta verenpaineeseen ja sydämen lyöntitiheyteen. Tutkitut lääkkeet edustivat seuraavia verenpainelääkeryhmiä: metoprololi beetasalpaajia, karvediloli yhdistettyjä alfa- ja beetasalpaajia, lisinopriili ACE-estäjiä, eprosartaani angiotensiini II antagonisteja, amlodipiini kalsiumestäjiä ja hydroklooritiatsidi diureetteja. Tärkeimmät mitatut vasteet olivat systolisen ja diastolisen verenpaineen ja sydämen lyöntitiheyden tasot ja muutokset ennen kylmäaltistusta, kylmäaltistuksen aikana ja sen jälkeen. Lisäksi mitattiin lämpötilavasteita ja tuntemuksia. Normo- ja hypertensiiviset koehenkilöt altistettiin joko –15°C:seen 15 minuutin ajaksi (talvivaatetuksessa), 5°C:seen 45 minuutin ajaksi (minimaalisella vaatetuksella) tai tehtiin ns. käden kylmävesitesti (CPT). Testisarjoissa (–15°C) metoprololi, karvediloli, lisinopriili, eprosartaani ja hydroklooritiatsidi tai plasebo annettiin viikon ajan kaksoissokko- ja vaihtovuoromenetelmällä. Yhdessä testisarjassa (5°C ja CPT) koehenkilöt ottivat amlodipiinia 3 päivän ajan tai olivat ilman lääkettä ennen testikertoja vaihtovuoroisessa järjestyksessä. Kaikki kylmäaltistustyypit nostivat merkittävästi sekä systolista että diastolista verenpainetta. Systolisen ja diastolisen verenpaineen nousu oli korkeampi koko kehon kylmäaltistuksissa (5°C tai –15°C) (19–35/20–24 mmHg) kuin ns. kylmävesitestissä (13/16 mmHg). Metoprololi, karvediloli, lisinopriili, eprosartaani ja amlodipiini laskivat verenpaineen tasoja koko kehon kylmäaltistuksessa verrattuna plaseboon. Yksikään verenpainelääkkeistä ei vaikuttanut merkittävästi kylmän aiheuttamaan verenpaineen nousuun verrattuna tutkimuskertaan ilman lääkettä tai plaseboon. Sydämen lyöntitiheys nousi ns. kylmävesitestin aikana, mutta laski koko kehon kylmäaltistuksissa (5°C ja –15°C). Metoprololi ja karvediloli laskivat sydämen lyöntiheyttä kylmäaltistuksessa (–15°C) verrattuna plaseboon. Tämä tutkimus kuvaa ensimmäistä kertaa, kuinka verenpainelääkkeet vaikuttavat verenpainetasoihin ja -vasteisiin kylmäaltistuksessa, joka simuloi tyypillisiä ulko-olosuhteita talvella. Vaikka lääkkeet eivät estäneet kylmän aiheuttamaa verenpaineen nousua, ne laskivat verenpaineen tasoa, jolloin verenpaine pysyi kylmässäkin lähempänä suositusrajoja
Filho, Gilberto Senechal de Goffredo. « Incapacidade temporária para atividades habituais : relação com a pressão arterial e o uso de terapia farmacológica antihipertensiva no Estudo Pró-Saúde ». Universidade do Estado do Rio de Janeiro, 2008. http://www.bdtd.uerj.br/tde_busca/arquivo.php?codArquivo=5021.
Texte intégralArterial hypertension (AH) plays a determinant role in the occurrence of severe clinical events; however, there are controversies about its impact on daily life. The temporary disability for daily activities, which is defined as a temporary restriction in an individuals usual level of functioning, is a health indicator proposed by the World Health Organization for utilization in population studies. To investigate the association between arterial hypertension and temporary disability for daily activities, we proposed the following specific objectives: A) To investigate whether elevated blood pressure (BP) determine the frequency or accumulated period of temporary disability for daily activities; 2) To investigate whether the use of anti-hypertensive drugs are associated with changes in the frequency or accumulated period of temporary disability for daily activities. We have a cross-sectional study with data obtained from 2953 participants who answered a self administered questionnaire in the Pro-Saude Study, a cohort of university employees in Rio de Janeiro state. The exposure was evaluated using the measured value of BP and the report of the use of anti-hypertensive drugs. We conducted the analysis classifying the participants in 4 groups, combining the information about measured BP (< or 140/90 mmHg) and the report of the use of anti-hypertensive drugs or not. The outcome was evaluated with a composite variable with information about the report and period of disability. Multivariate analyses were conducted using multinomial logistic regression. The results are 690 (23.4 %) were classified as hypertensives, and 704 (23.8 %) reported temporary disability. The use of antihypertensive drugs, among the participants with BP < 140/90 mmHg, was directly associated with the prevalence of temporary disability for daily activities for a longer period (OR=2.25, CI 95 %: 1.31 - 3.87). The presence of BP 140/90 mmHg showed an inverse relationship with the chance of temporary disability for a short period among the participants that did not use ntihypertensive drugs, not reaching statistical significance (OR=0.64; CI 95 %: 0.40 - 1.03). We found a direct association between the use of anti-hypertensive drugs and temporary disability for daily activities for a long period, which may be related to adverse effects of the drugs; the results also suggest an inverse relationship between BP values and the prevalence of temporary disability for a short period, which did not reach statistical significance, and can be related to a phenomenon known as AH-asociated hypalgesia.
Forino, Andrew Stephen. « Determining Effects of the PAF-R and Anti-Hypertensive Drugs Mediated Microvesicle Particle Release in Modulating Anti-Tumor Response of Lung Cancer ». Wright State University / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=wright1590691151424173.
Texte intégralMerlo, Juan. « Pharmacoepidemiologic studies on cardiovascular drugs with special reference to the effectiveness and safety of blood pressure lowering drugs / ». Lund : Dept. of Community Medicine, Lund University, and the NEPI Foundation, 1998. http://books.google.com/books?id=c_BsAAAAMAAJ.
Texte intégralMoore, Suzanne P. « Adherence to randomised drug regimens of patients enrolled in the Second Australian National Blood Pressure Study : a description of the patterns of adherence and of factors influencing non-adherence / ». [St. Lucia, Qld.], 2001. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe16251.pdf.
Texte intégralYates, John. « Haemodynamic effects of vasoactive drugs in experimental portal hypertension ». Thesis, Liverpool John Moores University, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.337787.
Texte intégralYu, Zhen. « Altered drug responses in diabetic and hypertensive-diabetic cardiomyopathy ». Thesis, University of British Columbia, 1990. http://hdl.handle.net/2429/29406.
Texte intégralPharmaceutical Sciences, Faculty of
Graduate
Greer, I. A. « The effect of anti-hypertensive agents on platelets, prostacylin and thromboxane and observations on prostacyclin and thromboxane in normal and hypertensive pregnancy ». Thesis, University of Glasgow, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.380334.
Texte intégralLivres sur le sujet "HYPERTENSIVE DRUGS"
Heart attacks, hypertension, and heart drugs. Emmaus, Pa : Rodale Press, 1987.
Trouver le texte intégralM, Drayer Jan I., Lowenthal David T et Weber Michael A, dir. Drug therapy in hypertension. New York : Dekker, 1987.
Trouver le texte intégralSwitzerland) International Symposium Clonidine in Hypertension (1984 Geneva. Low dose oral and transdermal therapy of hypertension : International Symposium Clonidine in Hypertension, Geneva, 14th-16th June, 1984. Darmstadt : Steinkopff, 1985.
Trouver le texte intégral1947-, Martin John E., et Dubbert Patricia M, dir. Non-drug treatments for essential hypertension. New York : Pergamon Press, 1988.
Trouver le texte intégralH, Messerli Franz, et Opie Lionel H, dir. Combination drug therapy for hypertension. New York : Author's Pub. House, 1997.
Trouver le texte intégralMann, Samuel J. Hypertension and you : Old drugs, new drugs, and the right drugs for your high blood pressure. Lanham : Rowman & Littlefield Publishers, 2012.
Trouver le texte intégralvan, Zwieten P. A., et Greenlee William J, dir. Antihypertensive drugs. Amsterdam, the Netherlands : Harwood Academic Publishers, 1997.
Trouver le texte intégralH, Messerli Franz, dir. The Heart and hypertension. New York, N.Y : Yorke Medical Books, 1987.
Trouver le texte intégralBönner, Gerd. Prostacyclin and hypertension. Berlin : Springer-Verlag, 1990.
Trouver le texte intégralLower blood pressure without drugs : Curing your hypertension naturally. 2e éd. Garden City Park, NY : Square One Publishers, 2012.
Trouver le texte intégralChapitres de livres sur le sujet "HYPERTENSIVE DRUGS"
Iturrioz, Xavier, Annabelle Reaux, Le Goazigo et Catherine Llorens-Cortes. « Aminopeptidase Inhibitors as Anti-Hypertensive Drugs ». Dans Aminopeptidases in Biology and Disease, 229–50. Boston, MA : Springer US, 2004. http://dx.doi.org/10.1007/978-1-4419-8869-0_11.
Texte intégralKuriyama, Yoshihiro, Tohru Sawada et Teruo Omae. « Antihypertensive Drugs and Cerebral Circulation ». Dans How Should Elderly Hypertensive Patients Be Treated ?, 69–83. Tokyo : Springer Japan, 1989. http://dx.doi.org/10.1007/978-4-431-68340-7_5.
Texte intégralCockcroft, John R., et David J. Webb. « Phase I Trials on Anti-hypertensive Drugs ». Dans Early Phase Drug Evaluation in Man, 302–12. London : Macmillan Education UK, 1990. http://dx.doi.org/10.1007/978-1-349-10705-6_24.
Texte intégralVoicu, Victor, et Maria Dorobantu. « New Drugs for the Hypertensive Failing Heart ». Dans Updates in Hypertension and Cardiovascular Protection, 313–34. Cham : Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-93320-7_20.
Texte intégralNakamaru, Mitsuaki, Toshio Ogihara, Hiroshi Mikami, Fuminori Masugi, Jitsuo Higaki, Atsuhiro Otsuka, Takeshi Hata et Yuichi Kumahara. « Complications and the Choice of Antihypertensive Drugs in the Elderly ». Dans How Should Elderly Hypertensive Patients Be Treated ?, 213–18. Tokyo : Springer Japan, 1989. http://dx.doi.org/10.1007/978-4-431-68340-7_21.
Texte intégralSarros, G., H. Nastou, A. Nastos, V. Sarrou, N. Fotopoulos et J. Anastassopoulou. « Molecular Design and FT-IR Spectra of Hypertensive Drugs ». Dans Spectroscopy of Biological Molecules, 565–66. Dordrecht : Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0371-8_261.
Texte intégralKirpizidis, H. G. « Quality of Life, Drugs and Diet in Hypertensive Patients ». Dans Handbook of Disease Burdens and Quality of Life Measures, 2965–86. New York, NY : Springer New York, 2010. http://dx.doi.org/10.1007/978-0-387-78665-0_173.
Texte intégralAgrawal, S. S. « Development of Transdermal and Transbuccal Drug Delivery Systems for Cardioactive Drugs with Special Reference to Anti- Hypertensive Agents ». Dans Atherosclerosis, Hypertension and Diabetes, 229–46. Boston, MA : Springer US, 2003. http://dx.doi.org/10.1007/978-1-4419-9232-1_19.
Texte intégralEscher, Emanuel. « Angiotensin II Antagonists with Prolonged Duration of Action Possible Anti-Hypertensive Drugs ». Dans Molecular Biology of Brain and Endocrine Peptidergic Systems, 29–45. Boston, MA : Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-8801-2_3.
Texte intégralBernstein, Donald P. « How Should You Manage Anti-Hypertensive Drugs in Morbidly Obese Surgical Patients ? » Dans Controversies in the Anesthetic Management of the Obese Surgical Patient, 91–101. Milano : Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2634-6_8.
Texte intégralActes de conférences sur le sujet "HYPERTENSIVE DRUGS"
Wilson, J., M. A. Orchard, A. A. Spencer, J. A. Davies et C. R. M. Prentice. « TREATMENT OF RAISED BLOOD PRESSURE WITH NISOLDIPINE REDUCES "SPONTANEOUS" PLATELET AGGREGATION IN WHOLE BLOOD ». Dans XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644260.
Texte intégralMartins, A. V. V., J. G. A. L. Junior, L. A. Bortolotto, G. Lorenzi-Filho et L. F. Drager. « Insomnia is Common in Patients with Hypertension and Associated with Higher Need of Anti-hypertensive Drugs ». Dans XIX Congresso Brasileiro do Sono. Thieme Revinter Publicações Ltda., 2023. http://dx.doi.org/10.1055/s-0043-1770250.
Texte intégralSuryantara, A. A., I. Suyasa, Ni Kamaryati et Ida Diyu. « Determinant Factors Affecting Adherence of Hypertensive Patients to Taking Antihypertensive Drugs ». Dans The Bali Biennial International Conference on Health Sciences. SCITEPRESS - Science and Technology Publications, 2022. http://dx.doi.org/10.5220/0011940700003576.
Texte intégralYalcin, Huseyin C., Mohamed A. Elrayess, Hadeel T. Al-Jighefee, Mahmoud Khatib A. A. Al-Ruweidi, Shamma Almuraikhy et Hadi M. Yassine. « Soluble ACE2 and Angiotensin II levels Modulated in Hypertensive COVID-19 Patients treated with different Antihypertension Drugs ». Dans Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0085.
Texte intégralPrihayati, Apriliya, et Pujiyanto Pujiyanto. « Drug Utilization Pattern and Cost Estimates of Anti-Hypertensive Drugs in Pharmacies under the National Health Insurance Program ». Dans The 6th International Conference on Public Health 2019. Masters Program in Public Health, Graduate School, Universitas Sebelas Maret, 2019. http://dx.doi.org/10.26911/the6thicph-fp.04.06.
Texte intégralPrihayati, Apriliya, et Pujiyanto Pujiyanto. « Drug Utilization Pattern and Cost Estimates of Anti-Hypertensive Drugs in Pharmacies Under the National Health Insurance Program ». Dans The 6th International Conference on Public Health 2019. Masters Program in Public Health, Graduate School, Universitas Sebelas Maret, 2019. http://dx.doi.org/10.26911/the6thicph.04.60.
Texte intégralRajendran, Rasvini, et Zaitul Marlizawati Zainuddin. « The Determining Factors in Prescribing Anti-Hypertensive Drugs to First-Ever Ischemic Stroke Patients ». Dans 2016 International Conference on Industrial Engineering, Management Science and Application (ICIMSA). IEEE, 2016. http://dx.doi.org/10.1109/icimsa.2016.7504041.
Texte intégralDaudt, Pedro Eugênio Deboni, Alexandre Grunfeld Starling Jardim et Felipe Ibiapina dos Reis. « Arterial hypertension and cerebrovascular accidents. epidemiological profile of patients attended between 2013 and 2019 in Joinville, Santa Catarina, Brazil. » Dans XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.344.
Texte intégralDaudt, Pedro Eugênio Deboni, Alexandre Grunfeld Starling Jardim et Felipe Ibiapina dos Reis. « Arterial hypertension and cerebrovascular accidents. epidemiological profile of patients attended between 2013 and 2019 in Joinville, Santa Catarina, Brazil ». Dans XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.475.
Texte intégralVaibavi, S. R., Rahul Vaippully, Basudev Roy et Saumendra K. Bajpai. « Anti-hypertensive Calcium-Blocking Drugs Induce a Change in Viscoelasticity of Mcf-7 Cancer Cells ». Dans ICBET 2020 : 2020 10th International Conference on Biomedical Engineering and Technology. New York, NY, USA : ACM, 2020. http://dx.doi.org/10.1145/3397391.3397420.
Texte intégralRapports d'organisations sur le sujet "HYPERTENSIVE DRUGS"
Fillipin, Federico, Pamela Seron et Ruvistay Gutierrez-Arias. Effectiveness of antihypertensive drugs to prevent cognitive decline, mild cognitive impairment, and dementia. An overview of systematic reviews. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, décembre 2022. http://dx.doi.org/10.37766/inplasy2022.12.0057.
Texte intégralXin, Yuning, Hongyu Li, Gungyu Cheng, Junfeng Cui, Yinghui Liu, Aidong Liu, Xiaolin Xu, Pengfei Li et Huize Han. Evaluation of the Effectiveness and Safety of Acupuncture in the Treatment of Cervicogenic Hypertension A Protocol for Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, décembre 2022. http://dx.doi.org/10.37766/inplasy2022.12.0036.
Texte intégralLi, YueXin, YangXiao Chen, Lin Fu, YangHang Chen, Ni Ren, Qian Jiang, Ran Ma et al. A Bayesian Network Meta-analysis on the Efficacy and Safety of Novel Targeted Drugs for Type Ⅰ Pulmonary Hypertension. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, décembre 2020. http://dx.doi.org/10.37766/inplasy2020.12.0023.
Texte intégralZhao, Jing, Yuanyuan Zeng, Jieqiong Weng, Jingfang Zhang, Tingting Yao, Mengfei Yuan et Xiaoxu Shen. Evening dosing versus morning regimen drug therapy for hypertension : a meta-analysis of randomized controlled trial. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, août 2021. http://dx.doi.org/10.37766/inplasy2021.8.0005.
Texte intégralTreadwell, Jonathan R., James T. Reston, Benjamin Rouse, Joann Fontanarosa, Neha Patel et Nikhil K. Mull. Automated-Entry Patient-Generated Health Data for Chronic Conditions : The Evidence on Health Outcomes. Agency for Healthcare Research and Quality (AHRQ), mars 2021. http://dx.doi.org/10.23970/ahrqepctb38.
Texte intégralLifestyle changes may be more important than drugs for mild hypertension. National Institute for Health Research, janvier 2019. http://dx.doi.org/10.3310/signal-000713.
Texte intégralIntroducing magnesium sulphate for the management of pregnancy induced hypertension. Population Council, 2005. http://dx.doi.org/10.31899/rh16.1012.
Texte intégral